244 related articles for article (PubMed ID: 36248882)
21. Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4
Pušnik J; Richter E; Schulte B; Dolscheid-Pommerich R; Bode C; Putensen C; Hartmann G; Alter G; Streeck H
Cell Rep; 2021 Jun; 35(13):109320. PubMed ID: 34146478
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the Levels of Peripheral CD3
Aljabr W; Al-Amari A; Abbas B; Karkashan A; Alamri S; Alnamnakani M; Al-Qahtani A
Microbiol Spectr; 2022 Feb; 10(1):e0084521. PubMed ID: 35196808
[TBL] [Abstract][Full Text] [Related]
23. Assessment of changes in immune status linked to COVID-19 convalescent and its clinical severity in patients and uninfected exposed relatives.
Torres Rives B; Zúñiga Rosales Y; Mataran Valdés M; Roblejo Balbuena H; Martínez Téllez G; Rodríguez Pérez J; Caridad Marín Padrón L; Rodríguez Pelier C; Sotomayor Lugo F; Valdés Zayas A; Carmenate Portilla T; Sánchez Ramírez B; Carlos Silva Aycaguer L; Portal Miranda JA; Marcheco Teruel B
Immunobiology; 2022 May; 227(3):152216. PubMed ID: 35436751
[TBL] [Abstract][Full Text] [Related]
24. Off-the-Shelf Partial HLA Matching SARS-CoV-2 Antigen Specific T Cell Therapy: A New Possibility for COVID-19 Treatment.
Kim N; Lee JM; Oh EJ; Jekarl DW; Lee DG; Im KI; Cho SG
Front Immunol; 2021; 12():751869. PubMed ID: 35003063
[TBL] [Abstract][Full Text] [Related]
25. A Highly Specific Assay for the Detection of SARS-CoV-2-Reactive CD4
Zelba H; Worbs D; Harter J; Pieper N; Kyzirakos-Feger C; Kayser S; Seibold M; Bartsch O; Ködding J; Biskup S
J Immunol; 2021 Feb; 206(3):580-587. PubMed ID: 33298615
[TBL] [Abstract][Full Text] [Related]
26.
Viurcos-Sanabria R; Manjarrez-Reyna AN; Solleiro-Villavicencio H; Rizo-Téllez SA; Méndez-García LA; Viurcos-Sanabria V; González-Sanabria J; Arroyo-Valerio A; Carrillo-Ruíz JD; González-Chávez A; León-Pedroza JI; Flores-Mejía R; Rodríguez-Cortés O; Escobedo G
Front Immunol; 2022; 13():897995. PubMed ID: 35860236
[TBL] [Abstract][Full Text] [Related]
27. Immune modulation as a consequence of SARS-CoV-2 infection.
Gelmez MY; Oktelik FB; Tahrali I; Yilmaz V; Kucuksezer UC; Akdeniz N; Cetin EA; Kose M; Cinar C; Oguz FS; Besisik S; Koksalan K; Ozdemir O; Senkal N; Gul A; Tuzun E; Deniz G
Front Immunol; 2022; 13():954391. PubMed ID: 36110850
[TBL] [Abstract][Full Text] [Related]
28. Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19.
Liu Y; Tan W; Chen H; Zhu Y; Wan L; Jiang K; Guo Y; Tang K; Xie C; Yi H; Kuang Y; Luo Y
BMC Infect Dis; 2021 Jan; 21(1):79. PubMed ID: 33461503
[TBL] [Abstract][Full Text] [Related]
29. Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19.
Kazancioglu S; Yilmaz FM; Bastug A; Sakallı A; Ozbay BO; Buyuktarakci C; Bodur H; Yilmaz G
Viral Immunol; 2021 Jun; 34(5):342-351. PubMed ID: 33264073
[TBL] [Abstract][Full Text] [Related]
30. Enhanced SARS-CoV-2-Specific CD4
Pavan Kumar N; Moideen K; Nancy A; Selvaraj N; Renji RM; Munisankar S; Thangaraj JWV; Muthusamy SK; Kumar CPG; Bhatnagar T; Ponnaiah M; Ramasamy S; Velusamy S; Murhekar MV; Babu S
Viruses; 2022 Mar; 14(3):. PubMed ID: 35336918
[TBL] [Abstract][Full Text] [Related]
31. Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.
Havervall S; Ng H; Jernbom Falk A; Greilert-Norin N; Månberg A; Marking U; Laurén I; Gabrielsson L; Salomonsson AC; Aguilera K; Kihlgren M; Månsson M; Rosell A; Hellström C; Andersson E; Olofsson J; Skoglund L; Yousef J; Pin E; Lord M; Åberg M; Hedhammar M; Tegel H; Dönnes P; Phillipson M; Nilsson P; Klingström J; Mangsbo S; Hober S; Thålin C
J Intern Med; 2022 Jan; 291(1):72-80. PubMed ID: 34459525
[TBL] [Abstract][Full Text] [Related]
32. Limited Recognition of Highly Conserved Regions of SARS-CoV-2.
Swaminathan S; Lineburg KE; Ambalathingal GR; Crooks P; Grant EJ; Mohan SV; Raju J; Panikkar A; Le Texier L; Tong ZWM; Chew KY; Neller MA; Short KR; Gowda H; Gras S; Khanna R; Smith C
Microbiol Spectr; 2022 Feb; 10(1):e0278021. PubMed ID: 35196796
[TBL] [Abstract][Full Text] [Related]
33. Mild Cytokine Elevation, Moderate CD4
Jia R; Wang X; Liu P; Liang X; Ge Y; Tian H; Chang H; Zhou H; Zeng M; Xu J
Virol Sin; 2020 Dec; 35(6):734-743. PubMed ID: 32699972
[TBL] [Abstract][Full Text] [Related]
34. The laboratory tests and host immunity of COVID-19 patients with different severity of illness.
Wang F; Hou H; Luo Y; Tang G; Wu S; Huang M; Liu W; Zhu Y; Lin Q; Mao L; Fang M; Zhang H; Sun Z
JCI Insight; 2020 May; 5(10):. PubMed ID: 32324595
[TBL] [Abstract][Full Text] [Related]
35. Assessing SARS-CoV-2-specific T-cell reactivity in late convalescents and vaccinees: Comparison and combination of QuantiFERON and activation-induced marker assays, and relation with antibody status.
Gatti A; Zizzo G; De Paschale M; Tamburello A; Castelnovo L; Faggioli PM; Clerici P; Brando B; Mazzone A
PLoS One; 2023; 18(5):e0285728. PubMed ID: 37220145
[TBL] [Abstract][Full Text] [Related]
36. Dissecting CD8+ T cell pathology of severe SARS-CoV-2 infection by single-cell immunoprofiling.
Schreibing F; Hannani MT; Kim H; Nagai JS; Ticconi F; Fewings E; Bleckwehl T; Begemann M; Torow N; Kuppe C; Kurth I; Kranz J; Frank D; Anslinger TM; Ziegler P; Kraus T; Enczmann J; Balz V; Windhofer F; Balfanz P; Kurts C; Marx G; Marx N; Dreher M; Schneider RK; Saez-Rodriguez J; Costa I; Hayat S; Kramann R
Front Immunol; 2022; 13():1066176. PubMed ID: 36591270
[TBL] [Abstract][Full Text] [Related]
37. A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19).
Mohammed RN; Tamjidifar R; Rahman HS; Adili A; Ghoreishizadeh S; Saeedi H; Thangavelu L; Shomali N; Aslaminabad R; Marofi F; Tahavvori M; Danshina S; Akbari M; Ercan G
Cell Commun Signal; 2022 Jun; 20(1):79. PubMed ID: 35655192
[TBL] [Abstract][Full Text] [Related]
38. Longitudinal Dynamics of Cellular Responses in Recovered COVID-19 Patients.
Cheng ML; Liu HY; Zhou C; Li RT; Zheng J; Qin YH; Yang N; Zhang Y; Huang JJ; Zhu Z; Meng QY; Wang GQ; Zhao H; Chen Y; Bai CQ; Qin CF; Li F
Front Immunol; 2022; 13():911859. PubMed ID: 35663993
[TBL] [Abstract][Full Text] [Related]
39. SARS-CoV-2 spike glycoprotein-reactive T cells can be readily expanded from COVID-19 vaccinated donors.
Taborska P; Lastovicka J; Stakheev D; Strizova Z; Bartunkova J; Smrz D
Immun Inflamm Dis; 2021 Dec; 9(4):1452-1467. PubMed ID: 34314576
[TBL] [Abstract][Full Text] [Related]
40. OX40 agonist stimulation increases and sustains humoral and cell-mediated responses to SARS-CoV-2 protein and saRNA vaccines.
Duhen R; Beymer M; Jensen SM; Abbina S; Abraham S; Jain N; Thomas A; Geall AJ; Hu HM; Fox BA; Weinberg AD
Front Immunol; 2022; 13():896310. PubMed ID: 36238275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
